Showing 2,658 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Access to healthcare

Access to highly effective hepatitis C treatment in Portugal: A Community Perspective

Editor's pick
EATG
19 December 2016
Pharmaceutical industry

Gilead’s Patent Loss to Merck Started With a Broken Friendship

Editor's pick
Bloomberg
19 December 2016
Access to healthcare

Hepatitis C patients 'go abroad for drugs'

Editor's pick
BBC Radio 4 (audio)
19 December 2016
Pharmaceutical industry

Merck wins $2.54 billion in hepatitis C drug trial against Gilead

Editor's pick
Reuters
16 December 2016
Hepatitis C transmission & prevention

Almost half of MSM with HIV/HCV co-infection have HCV in their rectal fluid

News
8 December 2016
People who inject drugs

Sofosbuvir-based therapy achieves excellent SVR12 rates among people who inject drugs in Ukraine

News
7 December 2016
Hepatitis C symptoms & diagnosis

First WHO prequalified hepatitis C rapid test opens the door to expanded treatment

Editor's pick
World Health Organization
5 December 2016
Hepatitis C treatment

Hepatitis C drugs Australia's most expensive, cost taxpayers $1 billion in four months

Editor's pick
ABC Online
5 December 2016
Hepatitis C transmission & prevention

Hepatitis C virus infection is rising among gay and bisexual men in San Diego

News
5 December 2016
Access to healthcare

New WHO report shows strategic purchasing of medicines can improve access in the European Region

Editor's pick
World Health Organization
2 December 2016
Hepatitis C transmission & prevention

Hepatitis C Sheds Enough in the Rectum to Transmit Through Anal Sex

Editor's pick
Poz
30 November 2016
Hepatitis C treatment

DAA treatment restricted for Canadian hepatitis C patients

Editor's pick
Medical Economics
29 November 2016
Hepatitis C treatment

Sofosbuvir/ledipasvir is effective for people with HIV/HCV co-infection in real-world clinical practice

News
28 November 2016
Hepatitis C treatment

Grazoprevir triple regimen demonstrates high cure rates, even for hard-to-treat people

News
25 November 2016
Hepatitis C treatment

People with HIV/HCV co-infection see good cure rates in real-world practice in Madrid

News
23 November 2016
Hepatitis C treatment

8-week triple DAA combo cures most people with genotype 1-6 hepatitis C

News
21 November 2016
Hepatitis C symptoms & diagnosis

Birth cohort screening and linkage to care for HCV treatment still weak in United States

News
18 November 2016
Hepatitis C treatment

AbbVie pangenotypic combination cures 98% or above across genotypes

News
16 November 2016
Hepatitis C treatment

AbbVie pangenotypic combination cures almost all hard-to-treat people with HCV genotype 3

News
16 November 2016
Hepatitis C treatment

US Veterans Affairs and Australia show potential for rapid elimination of hepatitis C

News
15 November 2016
Hepatitis B

Tenofovir alafenamide approved for hepatitis B, works well with less effect on bones

News
15 November 2016
Hepatitis C treatment

Grazoprevir/elbasvir + sofosbuvir highly effective for hard-to-treat genotype 3 hepatitis C patients

News
14 November 2016
Access to healthcare

Where hepatitis C rates are seven times the US average — and a cure is kept out of reach

Editor's pick
STAT
14 November 2016
Hepatitis C treatment

Liver cancer risk reduced after hepatitis C treatment, but vigilance needed for aggressive cancers in months after treatment

News
14 November 2016